| 2025-04-24 |
复牌提示：
2025-04-24 03:05:42 停牌，复牌日期 2025-04-25 09:40:00
|
| 2025-04-10 |
详情>>
拆分方案：
每20.0000股拆分成27.0000股
|
| 2025-03-31 |
详情>>
股本变动：
变动后总股本242.20万股
|
| 2025-03-31 |
详情>>
业绩披露：
2024年年报每股收益-0.1美元,归母净利润-16.8万美元,同比去年增长99.26%
|
| 2025-03-27 |
财报披露：
美东时间 2025-03-27 盘后发布财报
|
| 2025-01-28 |
股东大会：
将于2025-02-19召开股东大会
会议内容 ▼▲
- 1.The change of the legal name of Better Choice from “Better Choice Company, Inc.” to “SRX Health Solutions, Inc.” and of the NYSE ticker symbol from “BTTR” to “SRXH” (the “Name Change Proposal”).
2.The issuance of up to 30,000,000 shares of Better Choice common stock in connection with a proposed arrangement (the “Arrangement”) with SRx Health Solutions, Inc., a corporation organized under the laws of the Province of Ontario (“SRx”), pursuant to which Better Choice will acquire SRx, in accordance with the requirements of the NYSE American (the “Arrangement Proposal”);
3.An increase in the number of securities subject to the Better Choice Company, Inc. 2019 Incentive Award Plan (the “Plan Proposal”);
4.The approval of the postponement or adjournment of the Special Meeting to solicit additional proxies if there are not sufficient votes to approve the Arrangement Proposal and/or the Plan Proposal, if deemed necessary or appropriate by the Better Choice Board (the “Adjournment Proposal”);
|
| 2024-11-14 |
详情>>
业绩披露：
2024年三季报(累计)每股收益1.07美元,归母净利润134.90万美元,同比去年增长116.72%
|
| 2024-11-05 |
股东大会：
将于2024-12-18召开股东大会
会议内容 ▼▲
- 1.The election of our directors;
2.The approval, on a non-binding, advisory basis, of the compensation of our named executive officers (the “Advisory Proposal”);
3.The ratification of the appointment of Marcum LLP as our independent registered public accountant for 2024 (the “Accountant Proposal”);
4.To transact any other business as may properly come before the meeting or any adjournment or postponement thereof (the “Adjournment Proposal”).
|
| 2024-08-14 |
详情>>
业绩披露：
2024年中报每股收益-0.21美元,归母净利润-17.6万美元,同比去年增长97.27%
|
| 2024-05-17 |
详情>>
业绩披露：
2024年一季报每股收益-3.6美元,归母净利润-283万美元,同比去年增长18.77%
|
| 2024-04-12 |
详情>>
业绩披露：
2023年年报每股收益-32.29美元,归母净利润-2277万美元,同比去年增长42.08%
|
| 2024-03-21 |
详情>>
拆分方案：
每44.0000合并分成1.0000股
|
| 2023-11-14 |
详情>>
业绩披露：
2023年三季报(累计)每股收益-0.26美元,归母净利润-806.9万美元,同比去年增长46.04%
|
| 2023-09-26 |
股东大会：
将于2023-11-13召开股东大会
会议内容 ▼▲
- 1.To elect of our directors;
2.To approve the issuance of common stock upon exercise of the Alphia Second Tranche Warrant;
3.To approve the reappointment of BDO USA, LLP as our independent registered public accountants for 2023;
4.To approve, on an advisory basis, the Company’s executive compensation;
5.To transact any other business as may properly come before the meeting or any adjournment or postponement thereof.
|
| 2023-08-21 |
详情>>
业绩披露：
2023年中报每股收益-0.21美元,归母净利润-644.8万美元,同比去年增长23.30%
|
| 2023-05-12 |
详情>>
业绩披露：
2023年一季报每股收益-0.11美元,归母净利润-348.4万美元,同比去年增长13.76%
|
| 2023-03-28 |
详情>>
业绩披露：
2022年年报每股收益-1.34美元,归母净利润-3931.6万美元,同比去年增长-1260.79%
|
| 2023-01-31 |
详情>>
内部人交易：
Conacher Lionel F.股份增加18021.00股
|
| 2022-11-10 |
详情>>
业绩披露：
2022年三季报(累计)每股收益-0.51美元,归母净利润-1495.4万美元,同比去年增长-276.55%
|
| 2022-04-29 |
股东大会：
将于2022-06-13召开股东大会
会议内容 ▼▲
- 1.To elect directors;
2.To ratify the appointment of BDO USA, LLP as our independent registered public accounting firm for the fiscal year ending 2022;
3.An advisory resolution on executive compensation;
4.To adopt a one year frequency on future advisory votes on executive compensation;
5.To transact any other business as may properly come before the Annual Meeting or at any adjournment or postponement thereof.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|